Keel Point’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $398K | Sell |
5,092
-230
| -4% | -$18K | 0.03% | 344 |
|
|
2025
Q1 | $386K | Buy |
5,322
+508
| +11% | +$36.8K | 0.03% | 299 |
|
|
2024
Q4 | $356K | Buy |
4,814
+976
| +25% | +$72.3K | 0.03% | 292 |
|
|
2024
Q3 | $253K | Sell |
3,838
-135
| -3% | -$8.91K | 0.02% | 370 |
|
|
2024
Q2 | $264K | Buy |
3,973
+924
| +30% | +$61.3K | 0.02% | 341 |
|
|
2024
Q1 | $291K | Buy |
3,049
+13
| +0.4% | +$1.24K | 0.03% | 287 |
|
|
2023
Q4 | $231K | Buy |
3,036
+91
| +3% | +$6.94K | 0.03% | 301 |
|
|
2023
Q3 | $204K | Sell |
2,945
-156
| -5% | -$10.8K | 0.03% | 295 |
|
|
2023
Q2 | $293K | Buy |
3,101
+140
| +5% | +$13.2K | 0.04% | 251 |
|
|
2023
Q1 | $245K | Buy |
2,961
+107
| +4% | +$8.85K | 0.04% | 256 |
|
|
2022
Q4 | $213K | Sell |
2,854
-122
| -4% | -$9.1K | 0.03% | 268 |
|
|
2022
Q3 | $246K | Buy |
2,976
+89
| +3% | +$7.36K | 0.04% | 207 |
|
|
2022
Q2 | $300K | Sell |
2,887
-565
| -16% | -$58.7K | 0.05% | 200 |
|
|
2022
Q1 | $406K | Buy |
3,452
+154
| +5% | +$18.1K | 0.06% | 173 |
|
|
2021
Q4 | $427K | Buy |
3,298
+234
| +8% | +$30.3K | 0.05% | 167 |
|
|
2021
Q3 | $347K | Sell |
3,064
-28
| -0.9% | -$3.17K | 0.04% | 178 |
|
|
2021
Q2 | $320K | Buy |
3,092
+118
| +4% | +$12.2K | 0.04% | 187 |
|
|
2021
Q1 | $249K | Buy |
2,974
+211
| +8% | +$17.7K | 0.02% | 225 |
|
|
2020
Q4 | $252K | Buy |
2,763
+5
| +0.2% | +$456 | 0.02% | 208 |
|
|
2020
Q3 | $220K | Buy |
+2,758
| New | +$220K | 0.02% | 197 |
|